---
title: "NanoVibronix (NAOV.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NAOV.US.md"
symbol: "NAOV.US"
name: "NanoVibronix"
industry: "Health Care Equipment"
datetime: "2026-04-14T22:03:52.695Z"
locales:
  - [en](https://longbridge.com/en/quote/NAOV.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NAOV.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NAOV.US.md)
---

# NanoVibronix (NAOV.US)

## Company Overview

NanoVibronix, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers UroShield Ultra, which is designed to prevent bacterial colonization and biofilm formation in urinary catheters; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides PainShield MD, a single patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; PainShield Plus, a dual patch-based therapeutic ultrasound technology; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-04-14T04:30:16.000Z

**Overall: D (0.67)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 170 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -18.41% |  |
| Net Profit YoY | -48.46% |  |
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |
| Revenue | 2685000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -20.67% | E |
| Profit Margin | -251.92% | E |
| Gross Margin | 26.18% | C |
| Revenue YoY | -18.41% | E |
| Net Profit YoY | -48.46% | D |
| Total Assets YoY | 1061.53% | A |
| Net Assets YoY | 2168.38% | A |
| Cash Flow Margin | -58.59% | E |
| OCF YoY | -18.41% | E |
| Turnover | 0.09 | E |
| Gearing Ratio | 21.92% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - NanoVibronix",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-18.41%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-48.46%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "0.00",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2685000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-20.67%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-251.92%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "26.18%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-18.41%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-48.46%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "1061.53%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "2168.38%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-58.59%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-18.41%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.09",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "21.92%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.02 | 82/183 | - | - | - |
| PB | 0.11 | 2/183 | 0.14 | 0.11 | 0.08 |
| PS (TTM) | 1.75 | 47/183 | 2.02 | 1.75 | 0.98 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Abbott Laboratories (ABT.US) | B | C | C | C | B | B |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | B | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | B | B | C | C | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NAOV.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NAOV.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NAOV.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NAOV.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**